CentriMag RVAS U.S. Post-approval Study Protocol

Completed · Not applicable

Conditions studied: Right Ventricular Failure

In brief

The study objective is to gather post-market clinical data on the use of the CentriMag RVAS when used for temporary mechanical circulatory support of the right ventricle in patients with acute right ventricular failure from any cause

Key facts

Study ID

NCT01568424

Run by

Abbott Medical Devices

People needed

25

Starts

2009-09-01

Expected to finish

2014-06-01

Last updated by the study team

2022-06-27

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Right ventricular failure from any cause

You may not qualify if…

• Primary coagulopathy or platelet disorders
• Allergy or sensitivity to heparin and all alternative anticoagulants

Where it is running

• Mayo Clinic Hospital Arizona — Phoenix, Arizona, United States
• University of Kentucky — Lexington, Kentucky, United States
• University of Minnesota — Minneapolis, Minnesota, United States
• New York Columbia Presbyterian Hospital — New York, New York, United States
• University of Rochester Medical Center — Rochester, New York, United States
• Duke University Medical Center — Durham, North Carolina, United States
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
• St. Luke's Episcopal Medical Center — Houston, Texas, United States
• Intermountain Medical Center — Murray, Utah, United States
• University of Utah — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.